{"id":"https://openalex.org/W4392701435","doi":"https://doi.org/10.1158/1940-6207.c.6544800.v1","title":"Data from A Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial of Lovastatin for Various Endpoints of Melanoma Pathobiology","display_name":"Data from A Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial of Lovastatin for Various Endpoints of Melanoma Pathobiology","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4392701435","doi":"https://doi.org/10.1158/1940-6207.c.6544800.v1"},"language":"en","primary_location":{"id":"doi:10.1158/1940-6207.c.6544800.v1","doi":"https://doi.org/10.1158/1940-6207.c.6544800.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1940-6207.c.6544800.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/1940-6207.c.6544800.v1","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5057233825","display_name":"Kenneth G. Linden","orcid":"https://orcid.org/0009-0006-4681-2452","observed_orcids":["https://orcid.org/0009-0006-4681-2452"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kenneth G. Linden","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036941849","display_name":"Sancy Ann Leachman","orcid":"https://orcid.org/0000-0001-9140-0648","observed_orcids":["https://orcid.org/0000-0001-9140-0648"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sancy A. Leachman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021981756","display_name":"Jonathan S. Zager","orcid":"https://orcid.org/0000-0002-6886-4468","observed_orcids":["https://orcid.org/0000-0002-6886-4468"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jonathan S. Zager","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009729746","display_name":"James G. Jakowatz","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James G. Jakowatz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080636708","display_name":"Jaye L. Viner","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jaye L. Viner","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103071787","display_name":"Christine E. McLaren","orcid":"https://orcid.org/0000-0002-7932-9903","observed_orcids":["https://orcid.org/0000-0002-7932-9903"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christine E. McLaren","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113639716","display_name":"Ronald J. Barr","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ronald J. Barr","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082537748","display_name":"Philip M. Carpenter","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Philip M. Carpenter","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019815608","display_name":"Wen\u2010Pin Chen","orcid":"https://orcid.org/0000-0002-0143-5642","observed_orcids":["https://orcid.org/0000-0002-0143-5642","https://orcid.org/0009-0001-1950-4634"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wen-Pin Chen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000607672","display_name":"Craig A. Elmets","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Craig A. Elmets","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082067229","display_name":"Joseph A. Tangrea","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joseph A. Tangrea","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109157182","display_name":"Sung\u2010Jig Lim","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sung-Jig Lim","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111760856","display_name":"Alistair J. Cochran","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alistair J. Cochran","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5060872059","display_name":"Frank Louis Meyskens","orcid":"https://orcid.org/0000-0002-8827-4334","observed_orcids":["https://orcid.org/0000-0002-8827-4334"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Frank L. Meyskens","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.7368000149726868,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.7368000149726868,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12465","display_name":"Cancer, Lipids, and Metabolism","score":0.2386000007390976,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.014800000004470348,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lovastatin","display_name":"lovastatin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.8550000190734863},{"id":"https://openalex.org/keywords/chemoprevention","display_name":"chemoprevention","score":0.9200000166893005},{"id":"https://openalex.org/keywords/dysplastic-nevi","display_name":"dysplastic nevi","score":0.9340000152587891},{"id":"https://openalex.org/keywords/melanoma-pathogenesis","display_name":"melanoma pathogenesis","score":0.7870000004768372},{"id":"https://openalex.org/keywords/lipid-lowering-drugs","display_name":"lipid-lowering drugs","score":0.7940000295639038},{"id":"https://openalex.org/keywords/serum-cholesterol","display_name":"serum cholesterol","score":0.6859999895095825},{"id":"https://openalex.org/keywords/ldl-cholesterol","display_name":"LDL cholesterol","score":0.8769999742507935},{"id":"https://openalex.org/keywords/biomarkers","display_name":"biomarkers","score":0.5379999876022339}],"concepts":[{"id":"https://openalex.org/C2780940807","wikidata":"https://www.wikidata.org/wiki/Q417740","display_name":"Lovastatin","level":3,"score":0.8685541152954102},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7288559079170227},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.6785574555397034},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5949840545654297},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5843960046768188},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4997725486755371},{"id":"https://openalex.org/C2991744798","wikidata":"https://www.wikidata.org/wiki/Q608510","display_name":"Double blind","level":4,"score":0.48496556282043457},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.4786739945411682},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.43341535329818726},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4136936664581299},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.10380187630653381},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.09634533524513245},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.061694592237472534}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1940-6207.c.6544800.v1","doi":"https://doi.org/10.1158/1940-6207.c.6544800.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1940-6207.c.6544800.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1940-6207.c.6544800.v1","doi":"https://doi.org/10.1158/1940-6207.c.6544800.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1940-6207.c.6544800.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2071625393","https://openalex.org/W1486945226","https://openalex.org/W2097965253","https://openalex.org/W2029625896","https://openalex.org/W1990468128","https://openalex.org/W2098547698","https://openalex.org/W1522624035","https://openalex.org/W3009154995","https://openalex.org/W2518975089","https://openalex.org/W2117046467"],"abstract_inverted_index":{"Abstract":[0],"On":[1],"the":[2,18,24,38,78,89,100,105,114,133,184,198,218,226],"basis":[3],"of":[4,9,20,40,45,103,107,113,117,132,186,200,213,228],"large":[5],"cardiovascular":[6],"clinical":[7,35,119],"trials":[8],"lipid-lowering":[10],"agents":[11,235],"that":[12,192],"showed":[13,92],"a":[14,32,65,155],"considerable":[15,158],"decrease":[16,159],"in":[17,23,77,88,95,99,111,126,130,141,160,180,231],"incidence":[19,199],"primary":[21,101],"melanomas":[22],"active":[25],"agent":[26],"arm,":[27],"we":[28],"have":[29],"carried":[30],"out":[31],"randomized,":[33,84],"double-blind":[34],"trial":[36],"examining":[37],"impact":[39,121],"lovastatin":[41,61,146,151,194],"on":[42,122],"various":[43],"biomarkers":[44,72],"melanoma":[46,229],"pathogenesis.":[47],"Subjects":[48],"with":[49,97,148,171],"at":[50],"least":[51],"two":[52,79],"clinically":[53],"atypical":[54,215],"nevi":[55,216],"were":[56,73,83,137,195],"randomized":[57],"to":[58,196,206],"receive":[59],"oral":[60],"or":[62],"placebo":[63,98],"for":[64,75,145],"6-month":[66,219],"period.":[67],"Clinical,":[68],"histopathologic,":[69],"and":[70,86,157,164,230],"molecular":[71,134],"evaluated":[74],"change":[76],"groups.":[80],"Eighty":[81],"subjects":[82],"evaluable,":[85],"included":[87],"analyses.":[90],"Lovastatin":[91],"no":[93,138],"benefit":[94],"comparison":[96],"endpoint":[102],"decreasing":[104,118],"level":[106],"histopathologic":[108],"atypia,":[109,120],"nor":[110,125],"any":[112,131],"secondary":[115],"endpoints":[116],"nevus":[123],"number,":[124],"showing":[127],"significant":[128,139,156],"changes":[129],"biomarkers.":[135],"There":[136],"differences":[140],"adverse":[142],"event":[143],"profiles":[144],"compared":[147,170],"placebo.":[149],"The":[150],"arm":[152],"did":[153],"show":[154],"total":[161],"serum":[162,165],"cholesterol":[163],"low-density":[166],"lipoprotein":[167],"(LDL)":[168],"levels":[169],"placebo,":[172],"an":[173],"expected":[174],"result.":[175],"This":[176],"finding":[177],"bolsters":[178],"confidence":[179],"subject":[181],"compliance.":[182],"Given":[183],"results":[185],"this":[187],"trial,":[188],"it":[189,202],"is":[190,236],"concluded":[191],"if":[193],"lower":[197],"melanoma,":[201],"would":[203],"appear":[204],"not":[205],"be":[207],"doing":[208],"so":[209],"by":[210],"reversing":[211],"atypia":[212],"precursor":[214],"over":[217],"time":[220],"frame":[221],"studied.":[222],"Further":[223],"research":[224],"into":[225],"pathogenesis":[227],"other":[232],"potential":[233],"chemopreventive":[234],"needed.":[237],"Cancer":[238],"Prev":[239],"Res;":[240],"7(5);":[241],"496\u2013504.":[242],"\u00a92014":[243],"AACR.":[244]},"counts_by_year":[],"updated_date":"2026-09-24T07:57:37.273135","created_date":"2024-03-13T00:00:00"}